SOA Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69K Sell
363
-91
-20% -$15.6K 0.01% 333
2026
Q1
$76.7K Hold
454
0.01% 299
2025
Q4
$76.6K Hold
454
0.01% 308
2025
Q3
$65.5K Sell
454
-128
-22% -$17.5K 0.01% 342
2025
Q2
$73.7K Sell
582
-186
-24% -$22.8K 0.01% 311
2025
Q1
$98.3K Sell
768
-24
-3% -$3.25K 0.02% 262
2024
Q4
$105K Hold
792
0.02% 247
2024
Q3
$115K Buy
792
+1
+0.1% +$145 0.02% 239
2024
Q2
$109K Hold
791
0.02% 241
2024
Q1
$109K Buy
791
+1
+0.1% +$137 0.02% 236
2023
Q4
$107K Buy
790
+1
+0.1% +$122 0.02% 228
2023
Q3
$96.5K Hold
789
0.02% 230
2023
Q2
$100K Sell
789
-222
-22% -$28.8K 0.02% 234
2023
Q1
$131K Sell
1,011
-125
-11% -$16.4K 0.03% 201
2022
Q4
$149K Buy
1,136
+127
+13% +$16.4K 0.04% 184
2022
Q3
$118K Hold
1,009
0.04% 187
2022
Q2
$118K Hold
1,009
0.03% 190
2022
Q1
$131K Buy
1,009
+1
+0.1% +$130 0.03% 210
2021
Q4
$155K Sell
1,008
-80
-7% -$12.4K 0.04% 185
2021
Q3
$175K Buy
1,088
+210
+24% +$35.3K 0.04% 165
2021
Q2
$143K Sell
878
-7
-0.8% -$1.08K 0.04% 188
2021
Q1
$133K Buy
885
+88
+11% +$14K 0.04% 173
2020
Q4
$135K Buy
+797
New +$114K 0.04% 167

Other funds holding IBB

SOA Wealth Advisors's IBB Position: Q2 2026 in Review

SOA Wealth Advisors reduced its iShares Biotechnology ETF (IBB) stake by 20% in Q2 2026, selling an estimated $15.6K and leaving 363 shares worth $69K. The position accounts for 0.01% of the portfolio, ranked #333.

SOA Wealth Advisors first reported a position in IBB in Q4 2020 and has held it in 23 quarters since. The position peaked at $175K in Q3 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • SOA Wealth Advisors held 363 shares of iShares Biotechnology ETF worth $69K as of Q2 2026.
  • SOA Wealth Advisors sold 91 iShares Biotechnology ETF shares in Q2 2026, an estimated $15.6K.
  • iShares Biotechnology ETF made up 0.01% of SOA Wealth Advisors's portfolio in Q2 2026, its #333 holding.
  • SOA Wealth Advisors first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 23 quarters since.
  • SOA Wealth Advisors's iShares Biotechnology ETF position peaked at $175K in Q3 2021.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.